Papers about tirzepatide

Every paper here, unless its row says otherwiseIndexed under tirzepatide in PubMed; returned by a PubMed search for tirzepatide

• Evaluating the therapeutic impact of tirzepatide in people with partial lipodystrophy.

  The Journal of clinical endocrinology and metabolism2026PMID 41866320

• Weight Changes With Tirzepatide and Concomitant Weight-Inducing Medications: Post Hoc Analysis of Randomized Clinical Trials.

  JAMA network open2026PMID 41885866Also tests tirzepatide

• Real-World Cardiovascular Outcomes of Obesity Treatment With Tirzepatide Versus Semaglutide in Non-Diabetic Adults.

  Diabetes, obesity & metabolism2026PMID 41891334Indexed under tirzepatide in PubMed

• The adverse effects associated with tirzepatide use in patients at increased risk of cardiovascular events: a systematic review with meta-analysis and Trial Sequential Analysis.

  BMC medicine2026PMID 41896878Also tests tirzepatide

• Real-World Weight-Loss Outcomes in Weight-Reduced Patients Treated With Tirzepatide.

  Obesity (Silver Spring, Md.)2026PMID 41902614

• Ixekizumab With Tirzepatide Achieved Greater Disease Control Than Ixekizumab Alone in Adults With Psoriatic Arthritis and Overweight or Obesity: Results From a Randomized Clinical Trial.

  Arthritis & rheumatology (Hoboken, N.J.)2026PMID 41903163

• Cardiorenal Outcomes With Tirzepatide Compared With Dulaglutide in Patients With Diabetes and Cardiovascular Disease: A Post Hoc Analysis of the SURPASS-CVOT Randomized Clinical Trial.

  JAMA cardiology2026PMID 41903177

• Safety and efficacy of switching from dulaglutide to tirzepatide across clinically relevant baseline characteristics in participants with T2D: subgroup analysis of SURPASS-SWITCH.

  BMJ open diabetes research & care2026PMID 41912265

• Efficacy of tirzepatide, lanifibranor, and resmetirom in metabolic dysfunction-associated steatotic liver disease: a meta-analysis of high-quality randomized controlled trials.

  Internal and emergency medicine2026PMID 41917519Indexed under tirzepatide in PubMed's chemical list; returned by a PubMed search for tirzepatide

• Dose-response analysis of tirzepatide and acute pancreatitis: An international systematic review and quantitative meta-analysis of randomised trials.

  Pancreatology2026PMID 41927408Indexed under tirzepatide in PubMed's chemical list; returned by a PubMed search for tirzepatide

• Estimating the True MACE Benefits From Tirzepatide in SURPASS-CVOT Using an Imputed Placebo Analysis of REWIND.

  Diabetes care2026PMID 41940793Indexed under tirzepatide in PubMed's chemical list; returned by a PubMed search for tirzepatide

• Real-World Clinical Evidence of Tirzepatide for Metabolic Abnormalities in Subjects With Type 2 Diabetes: The Multicenter Retrospective Observational Hokkaido-TZP Study.

  Diabetes, obesity & metabolism2026PMID 41944182

• Short-Term Associations Between Fat-Free Mass Preservation and Glycaemic Markers During Tirzepatide Therapy: A Secondary Exploratory Analysis.

  Nutrients2026PMID 41978142

• Tirzepatide therapy reduces subclinical leaflet thrombosis and paravalvular leak after transcatheter aortic valve replacement in obese patients: The TAVR-MET trial.

  Cardiovascular revascularization medicine2026PMID 42000295

• Tirzepatide as Adjunct to Insulin in Adults With Type 1 Diabetes and Overweight or Obesity: A Systematic Review of Randomized and Real-World Evidence.

  Endocrinology, diabetes & metabolism2026PMID 42007544

• Comparative effectiveness of tirzepatide versus GLP-1 receptor agonists on cardiovascular-kidney-metabolic stage progression: a real-world cohort study.

  Diabetes research and clinical practice2026PMID 42009260

• Six-Month Real-World Effectiveness, Persistence and Safety of Low-to-Moderate Dose Tirzepatide in Adults With Obesity: A Multicentre Observational Study.

  Diabetes, obesity & metabolism2026PMID 42037110

• Indirect Comparative Efficacy and Safety of Tirzepatide Versus Oral Semaglutide for the Treatment of Overweight and Obesity.

  Diabetes, obesity & metabolism2026PMID 42050884Indexed under tirzepatide in PubMed

• Real-Life Data of Tirzepatide Use to Support Lifestyle Modification in Patients with Metabolic Syndrome.

  Nutrients2026PMID 42075085

• Short-term effect of tirzepatide on serum calcitonin in adults with obesity.

  Endocrine2026PMID 42081121

• Shifts in waist-to-height ratio categories within tirzepatide groups: a post-hoc analysis of SURMOUNT-1.

  Journal of endocrinological investigation2026PMID 42082865

• Pre-Pregnancy GLP-1 Receptor Agonist or Tirzepatide Use and Gestational Diabetes Risk: Evaluating Pharmacodynamic Carry-Over Versus Post-Discontinuation Metabolic Rebound in a Multinational Federated Cohort.

  Diabetes, obesity & metabolism2026PMID 42098901

• Effect of Tirzepatide on Health-Related Quality of Life in Japanese Patients With Obesity Disease: Patient-Reported Outcomes From the SURMOUNT-J Study.

  Diabetes, obesity & metabolism2026PMID 42108080

• A comparison of the effects of tirzepatide and dulaglutide on major kidney events in people with type 2 diabetes: pre-specified exploratory analyses of the SURPASS-CVOT trial.

  The lancet. Diabetes & endocrinology2026PMID 42114520Indexed under tirzepatide in PubMed's chemical list; returned by a PubMed search for tirzepatide

• Tirzepatide for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial.

  Lancet (London, England)2026PMID 42119587

• Ixekizumab With or Without Tirzepatide in Adults With Psoriasis and Overweight or Obesity: A Phase 3b Randomized Clinical Trial.

  JAMA dermatology2026PMID 42139049

• Impact of Tirzepatide Therapy on Thyroid Disease: Understanding Risks and Emerging Insights.

  Clinical obesity2026PMID 42145153

• Tirzepatide Versus Intensified Conventional Care After 2 Years of Treatment in Early Type 2 Diabetes : A Randomized Clinical Trial.

  Annals of internal medicine2026PMID 42184419

• Comparative Effectiveness of CagriSegma, Semaglutide, Cagrilintide and Tirzepatide in the Management of Overweight and Obesity: A Network Meta-Analysis of Randomized Clinical Trials.

  Endocrinology, diabetes & metabolism2026PMID 42207966Indexed under tirzepatide in PubMed's chemical list

• Comprehensive Long-Term Changes in Cardiovascular Risk Biomarkers With Tirzepatide: A SURMOUNT-1 Post Hoc Analysis.

  Journal of the American College of Cardiology2026PMID 42233927

• Short-Term Combined Treatment With Tirzepatide and Metformin for Overweight/Obese Chinese Women With Polycystic Ovary Syndrome: A Prospective, Open-Label, Randomised Controlled Trial.

  Diabetes, obesity & metabolism2026PMID 42236268Indexed under tirzepatide in PubMed's chemical list

• Tirzepatide for Recurrent Weight Gain after Bariatric Procedures: Real-World Evidence of Efficacy and Safety.

  Obesity surgery2026PMID 42247124

• Apitegromab for lean mass preservation during tirzepatide-induced weight loss: a randomized, double-blind, placebo-controlled phase 2 trial.

  Nature medicine2026PMID 42260100

• Post hoc analysis of SURMOUNT-J: tirzepatide versus placebo and predicted 10-year cardiovascular disease risk in Japanese adults with obesity disease.

  Current medical research and opinion2026PMID 42287159

• Effectiveness of tirzepatide in Japanese patients with type 2 diabetes but no obesity: A sub-analysis of Hokkaido-TZP study data.

  Journal of diabetes investigation2026PMID 42289805

• Sex, Not Age, Predicts Weight Loss Outcomes With Tirzepatide: A Retrospective Analysis.

  Obesity (Silver Spring, Md.)2026PMID 42290037

• Tirzepatide monotherapy in Chinese patients with early type 2 diabetes: A randomized, double-blind, placebo-controlled phase 3 trial (SURPASS-CN-MONO).

  Med (New York, N.Y.)2026PMID 42296968

• 1-year outcomes of semaglutide, tirzepatide, and sleeve gastrectomy in obesity in type 2 diabetes: a retrospective cohort study.

  The lancet. Diabetes & endocrinology2026PMID 42309121Indexed under tirzepatide in PubMed

• Tirzepatide Efficacy and Tolerability According to Early Weight Response: A Post Hoc Analysis of the SURMOUNT-1 and SURMOUNT-2 Trials.

  Diabetes, obesity & metabolism2026PMID 42348366

• Comparative real-world outcomes of tirzepatide vs semaglutide in patients with obesity and type2 diabetes: A retrospective propensity-matched cohort study.

  Diabetes & vascular disease research2026PMID 42376874Indexed under tirzepatide in PubMed

• Tirzepatide Is Associated With Improved Metabolic Outcomes in People With Type 1 Diabetes and Overweight or Obesity: A Retrospective Cohort Study.

  Diabetes, obesity & metabolism2026PMID 42387290

• Efficacy of tirzepatide versus SGLT2 inhibitors in metabolic dysfunction-associated steatotic liver disease (MASLD): a multicenter propensity-matched real-world study.

  Hepatology international2026PMID 42397506

• Cardiovascular Outcomes With Tirzepatide Versus GLP-1 Receptor Agonists in Overweight or Obesity: A Systematic Review and Meta-Analysis.

  Diabetes, obesity & metabolism2026PMID 42410309Also tests tirzepatide

• Real-World Effectiveness and Safety of Tirzepatide in Type 1 Diabetes and Obesity: Impact on Glycaemia, Weight, and Cardiometabolic Risk Markers.

  Diabetes, obesity & metabolism2026PMID 42410316

• Neuropsychiatric Outcomes With Tirzepatide, Semaglutide, and Other GLP-1 Receptor Agonists.

  Diabetes, obesity & metabolism2026PMID 42420795Indexed under tirzepatide in PubMed; tests tirzepatide

• Comparative effectiveness of tirzepatide and DPP-4 inhibitors in type 2 diabetes with heart failure.

  Diabetes & vascular disease research2026PMID 42420805

• Tirzepatide compared with semaglutide in obesity disease: a subpopulation analysis applying Japan Society for the Study of Obesity criteria in the global SURMOUNT-5 trial.

  Current medical research and opinion2026PMID 42434924Indexed under tirzepatide in PubMed

• Tirzepatide, cardiovascular outcomes and mortality in obesity and diabetes: a systematic review and meta-analysis.

  Diabetes research and clinical practice2026PMID 42442557

• Tirzepatide and reduced risk of pulmonary embolism and deep vein thrombosis: a multicenter U.S. cohort study.

  Frontiers in endocrinology2026PMID 42460324

• Effect of short-term tirzepatide treatment on mean platelet volume in patients with obesity: a retrospective controlled study.

  BMC endocrine disorders2026PMID 42464179